Muhammad Rizwan-Ul-Haq Khawaja MD MPD
Hematologic Oncology, Clinical Pharmacology
Associate Clinical Investigator
Join to view full profile
10510 N 92nd Street Suite 200Scottsdale, AZ 85258
Phone+1 480-323-1350
Dr. Khawaja is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Developmental Therapeutics In Oncology, 2015 - 2016
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015- Indiana University School of MedicineResidency, Internal Medicine, 2009 - 2012
Aga Khan Medical CollegeClass of 2006
Certifications & Licensure
AZ State Medical License 2022 - 2027
TX State Medical License 2017 - 2027
PA State Medical License 2017 - 2018
IN State Medical License 2013 - 2017
NM State Medical License 2016 - 2017
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Hematology- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
American Board of Medical QualityCertified in Medical Quality
Publications & Presentations
PubMed
- 4 citationsA phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer.Jibran Ahmed, Bettzy Stephen, Muhammad R Khawaja, Yali Yang, Israa Salih
Gynecologic Oncology. 2025-02-01 - 6 citationsHodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia.Taylor Linaburg, Adam R. Davis, Noelle V. Frey, Muhammad R. Khawaja, Daniel J. Landsburg
Plos One. 2019-04-05 - 146 citationsVISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML.Liru Wang, Bei Jia, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka
Oncoimmunology. 2018-07-11
Professional Memberships
- Member
- Member
- Member
Other Languages
- Hindi, Punjabi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: